Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Acquisitions (2016 - 2025)

Pediatrix Medical (MD) has disclosed Acquisitions for 17 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Acquisitions changed N/A to $4.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.2 million, a 184.02% increase, with the full-year FY2025 number at $23.2 million, up 184.02% from a year prior.
  • Acquisitions was $4.0 million for Q4 2025 at Pediatrix Medical, down from $19.2 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $25.7 million in Q1 2022 to a low of $1.2 million in Q2 2021.
  • A 5-year average of $8.7 million and a median of $6.0 million in 2021 define the central range for Acquisitions.
  • Peak YoY movement for Acquisitions: skyrocketed 7842.67% in 2021, then crashed 93.51% in 2023.
  • Pediatrix Medical's Acquisitions stood at $10.4 million in 2021, then crashed by 75.92% to $2.5 million in 2022, then surged by 100.0% to $5.0 million in 2023, then surged by 63.34% to $8.2 million in 2024, then plummeted by 51.02% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Acquisitions are $4.0 million (Q4 2025), $19.2 million (Q3 2025), and $8.2 million (Q1 2024).